Regenacy Pharmaceuticals
Waltham
About Regenacy Pharmaceuticals
Regenacy Pharmaceuticals they give services to treat diabetic and other peripheral neuropathies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $17.1M
- Funding stage: Early Stage Venture
- Last round: Series B (Aug 2022)
- Website: regenacy.com
- Phone: (617) 415-5030
Industries & Categories
Biotechnology, Health Care, Medical, Service Industry, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/regenacy-pharmaceuticals-93902 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.